1976
DOI: 10.1002/j.1879-3479.1976.tb00583.x
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term Use Effectiveness of the CU‐7‐200 IUD

Abstract: Copper‐containing IUDs have been demonstrated to be as good, if not better, than other presently used inert devices. There is, however, no consensus on the duration of contraceptive effectiveness of copper‐containing IUDs. The long‐term contraceptive effectiveness of one copper‐containing IUD, the CU‐7‐200 Gravigard®, is evaluated in this report on 514 patients. IUDs were inserted in the intermenstrual period and patients were followed up for as long as 63 months. The probability of pregnancy, expulsion, or re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1976
1976
1986
1986

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…The addition of copper or progesterone to the "T" vector significantly lowers the pregnancy rate. The 1-year pregnancy rate for the plain "T" is 18.2 per 100 women; for the Cu-T-200, it is 0.9-3.0 per 100 women; and for the Progestasert ® (a "T" device which releases progesterone at a rate of about 65 mcg/24 hours), it is 1.9-2.5 per 100 women (33,35).…”
Section: Pharmacologic Agentsmentioning
confidence: 99%
“…The addition of copper or progesterone to the "T" vector significantly lowers the pregnancy rate. The 1-year pregnancy rate for the plain "T" is 18.2 per 100 women; for the Cu-T-200, it is 0.9-3.0 per 100 women; and for the Progestasert ® (a "T" device which releases progesterone at a rate of about 65 mcg/24 hours), it is 1.9-2.5 per 100 women (33,35).…”
Section: Pharmacologic Agentsmentioning
confidence: 99%
“…Copper (13) and progesterone (8) have been added to small IUDs to improve their efficacy. It appears, however, that even with the addition of these adjuncts small carrier devices cannot match the efficacy of larger, standard inert devices for long-term use (1,12). The lack of success with modifications in shape and size have led investigators to consider both systemic and local administration of antifibrinolytic drugs for treatment of menorrhagia related to IUD use.…”
Section: Introductionmentioning
confidence: 99%